Skip to main content
Clinical Trials/IRCT20200825048514N1
IRCT20200825048514N1
Completed
Phase 3

The assessment of therapeutic effect of ß-interferon and Methylprednisolone in patients with COVID- 19: A quasi-experimental, double-blind, placebo-controlled study

Yazd University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Yazd University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 18\- 80 years
  • Covid\-19 infection based on high\-resolution computed tomography findings
  • Progressive and severe hypoxia based on blood oxygen saturation level less than 88% with a reservoir bag mask and flow of 15 liters
  • Exacerbation of lymphopenia during hospitalization

Exclusion Criteria

  • Cardiovascular patients
  • Grade 3 and more liver cirrhosis
  • Autoimmune diseases
  • Severe depression and psychosis
  • Organ transplantation
  • Kidney failure

Outcomes

Primary Outcomes

Not specified

Similar Trials